EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype with basal features, lacking the expression of receptors targeted successfully in other breast cancer subtypes. Treatment response to adjuvant and neoadjuvant chemotherapy is often short-lived and metastatic spre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ring, Alexander, Kaur, Pushpinder, Lang, Julie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653866/
https://www.ncbi.nlm.nih.gov/pubmed/33167919
http://dx.doi.org/10.1186/s12885-020-07573-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653866/
https://www.ncbi.nlm.nih.gov/pubmed/33167919
http://dx.doi.org/10.1186/s12885-020-07573-y

Ejemplares similares